SOPHiA GENETICS SA

4.5400+0.45 (+11%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · SOPH · USD

Upcoming Earnings

Report date
Nov 4, 2025 (in 5 days)

Key Stats

Market Cap
306.81M
P/E (TTM)
-
Basic EPS (TTM)
-1.10
Dividend Yield
0%

About

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

CEO
Dr. Jurgi Camblong M.B.A., Ph.D.
IPO
7/23/2021
Employees
423
Sector
Healthcare
Industry
Health Information Services